Spots Global Cancer Trial Database for Doxycycline for the Treatment of Cutaneous T-Cell Lymphoma
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Doxycycline for the Treatment of Cutaneous T-Cell Lymphoma
Official Title: Doxycycline in Patients With Relapsed Cutaneous T-cell Lymphoma
Study ID: NCT02341209
Interventions
Study Description
Brief Summary: This study looks at the efficacy of Doxycycline for the treatment of Cutaneous T-cell Lymphomas.
Detailed Description: The aim of this study is to evaluate the efficacy of doxycycline in relapsed Cutaneous T-cell Lymphomas (CTCL). The primary objective is to determine the overall response rate of doxycycline monotherapy in patients with relapsed CTCL.
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Rochester General Hospital, Rochester, New York, United States
Contact Details
Name: Brian Poligone, M.D. Ph.D.
Affiliation: Rochester General Hospital
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
